Vale, Baby Boy .
HRN: 23-76-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/03/2023
10/09/2023
IV
30mg
BID
Neonatal Pneumona
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes